Answers are grounded in this paper and cite their sources.
Single-cell transcriptomic analysis uncovers conserved fibro-inflammatory mechanisms in biliary atresia and PSC, implying shared therapeutic targets.
Primary sclerosing cholangitis (PSC) and biliary atresia (BA) both demonstrate the ductular reaction (DR), including biliary ductules, immune infiltration, and fibroblast activation. Advances in single-cell RNA sequencing and spatial transcriptomics have revolutionised our understanding of the DR fibro-inflammatory niche of these disorders. Recent studies using these techniques have also demonstrated that there are conserved mechanisms of fibro-inflammation across diseases and organ systems. Notably, epithelial, mesenchymal, and innate immune processes in the DR are shared between BA and PSC, including: pro-fibrogenic hepatocyte-to-cholangiocyte transdifferentiation, increased cholangiocyte senescence, accumulation of scar-/lipid-associated macrophages, Kupffer cell dysfunction, and activation of portal fibroblasts. In contrast, adaptive immune processes differ between the two disorders, including: transdifferentiation of Th17 into Th1 cells in BA, dominance of the Th17 axis in PSC, reduced CX3CR1 CD8/NKT-cells in BA, and gut-priming with liver-homing of lymphocytes in PSC. Future work needs to include a range of early- and late-stage disease samples, particularly non-cirrhotic PSC, and the use of single-cell spatial transcriptomic technologies will allow higher confidence in prediction of ligand-receptor interactions. These observations facilitate identification of therapeutic targets against conserved mechanisms of the DR applicable to multiple fibro-inflammatory disorders.
No takes yet. Share an insight, caveat, or question.
Schofield et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: